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Abstract. Programmed cell death is an ongoing process 
in both the developing and the mature nervous system. 
The tumor suppressor gene, p53, can induce apoptosis 
in a number of different cell types. Recently, the en- 
hanced expression of p53 has been observed during 
acute neurological disease. To determine whether p53 
overexpression could influence neuronal survival, we 
used a recombinant adenovirus vector carrying wild 
type p53 to transduce postmitotic neurons. A  control 
consisting of the same adenovirus vector background 
but carrying the lacZ reporter expression cassette was 
used to establish working parameters for the effective 
genetic manipulation of sympathetic neurons. We have 
found that recombinant adenovirus can be used at titers 
sufficiently high (10 to 50 multiplicity of infection) to 
transduce the majority of the neuronal population with- 
out perturbing survival, electrophysiological function, 
or cytoarchitecture. Moreover, we demonstrate that 
overexpression of wild type p53 is sufficient to induce 
programmed cell death in neurons. The observation 
that p53 is capable of inducing apoptosis in postmitotic 
neurons has major implications for the mechanisms of 
cell death in the traumatized mature nervous system. 
p 
ROGRAMMED cell death is an ongoing process in both 
the developing and the mature nervous system (for 
review see 38). Developing neurons have a default 
suicide program that predominates in the absence of tar- 
get-derived neurotrophins (6, 31).  In the mature nervous 
system, inappropriate  apoptosis  has  been  implicated in 
neurodegenerative diseases as well as acute neurological 
insults (22,  38, 42).  Defining the molecular mechanisms 
regulating apoptosis is the first step toward effective treat- 
ment strategies for such neurological diseases. 
The p53 tumor suppressor gene can induce apoptosis in 
a number of different cell types (for review see 12, 41). As 
a tumor suppressor, the primary role for p53 when induced 
after DNA damage is to mediate cell cycle arrest, p53-medi- 
ated growth arrest appears to be dependent on its tran- 
scriptional activation function whereby it binds to p53 con- 
sensus sequences on a number of promoters, such as that 
for the cyclin kinase inhibitor, p21  (WAF-1) (10,  11, 33). 
p21  can then mediate cell cycle arrest  and  prevent  the 
propagation of damaged DNA (15,  43).  The cellular re- 
sponse to enhanced expression of p53 varies depending on 
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the cell type and may lead to either growth arrest or apop- 
tosis (1,  18, 19, 33, 41). The precise mechanism by which 
p53 mediates apoptosis is not well understood, but it is be- 
lieved to proceed by a  number of mechanisms including 
direct transactivation, transcriptional repression,  and di- 
rect involvement in DNA cleavage (4, 12, 19, 28). 
While p53  has been shown to regulate apoptosis in a 
number of systems involving tumor cells, we questioned 
whether the p53 pathway could play any role in neuronal 
cell death. Studies with p53-deficient transgenic mice sug- 
gest that p53 is not required for apoptosis after neurotro- 
phin withdrawal (5, 7). Recently, however, p53 levels have 
been  shown to be  induced after acute neuronal disease 
(22, 36, 42). For example, enhanced expression of p53 has 
been observed before neuronal cell death after kainic acid 
treatment (36)  and  after focal ischemia  (22).  Radiation 
damage in cerebellar granule cells has also been shown to 
involve p53 mediated apoptosis (42).  In light of the fact 
that neurons are terminally differentiated cells, a role for 
p53 in neuronal cell death seems inconsistent with its func- 
tion as a tumor suppressor. To determine directly if p53 in- 
duction is sufficient to trigger the  onset of apoptosis in 
postmitotic neurons, we have used a recombinant adenovi- 
rus vector to deliver p53 to cultured sympathetic neurons. 
Recently, a number of studies have demonstrated that 
adenovirus-based vectors can effectively transduce post- 
mitotic neurons of the central nervous system (CNS)  in 
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view see 39). While these viral vectors appear to success- 
fully deliver reporter genes to postmitotic neurons, little is 
known as to how these agents may impact on the function 
of the recipient cell. If adenovirus-derived vectors are to 
be used to define the molecular pathways regulating apop- 
tosis, their influence on the biochemistry and physiology 
of the  neuron  must  first  be  understood.  In the  present 
study  we  evaluate  the  efficacy of adenoviral  vectors  as 
gene transfer agents to sympathetic neurons, as well as de- 
fine the parameters within which  they can be effectively 
used. To this end, a recombinant adenovirus carrying the 
lacZ reporter gene inserted in the deleted E1  region  (2) 
was used to transduce neurons from the superior cervical 
ganglia in vitro. Examination of infectivity and cytotoxic- 
ity, as well as cell physiology and cytoarchitecture, indi- 
cated that such adenovirus recombinants have the poten- 
tial to serve as effective gene transfer agents to sympathetic 
neurons.  Then,  working  within  the  parameters we  have 
defined, we introduced a wild-type human p53 expression 
cassette using the same vector backbone. These studies in- 
dicate  that  overexpression of p53  mediates  apoptosis  in 
cultured sympathetic neurons. The demonstration that p53 
is sufficient to induce  apopotosis in  postmitotic neurons 
has major implications for the mechanisms of cell death in 
the traumatized mature nervous system. 
Materials and Methods 
Viral Vectors 
The adenoviral recombinant carrying an Escherichia coli 13-galactosidase 
expression cassette with  a  cytomegalovirus promoter  (Ad5CA17LacZ) 
was kindly provided by Dr. Frank Graham (McMaster University, Hamil- 
ton, Ontario). The recombinant virus was generated by the cotransfection 
of PCA14(lacZ) and pJM17 as previously described (2). This El- and E3- 
deleted virus contained the reporter gene in the E1 region. The recombi- 
nant adenovirus carrying wild-type human p53 was constructed according 
to the method of Graham (2) and has been recently described (18). Re- 
sults obtained were verified with a second preparation of adenovirns vec- 
tor conferring p53 expression (Adwtp53), kindly provided by Dr. F. Gra- 
ham (1). Recombinant adenoviruses were amplified on 293 cells, a human 
embryo kidney cell line, expressing the adenovirus type 5 E1A and E1B 
proteins (14). These vectors were harvested from cell lysates and used di- 
rectly or further purified on CsCl gradients according to Graham and Pre- 
vec (14).  Infectious titer was determined by plaque assay on 293 cells as 
previously described  (14).  When comparing the effects of adenovirns- 
mediated p53 vs [3-galactosidase overexpression, we ensured that observa- 
tions were not attributable to differences in viral preparations by verifying 
that: (a) virus preparations being compared were purified in an identical 
manner; (b) several preparations of each virus were examined; (c) particle 
content (a potential source of cytotoxicity) was in a similar range; and (d) 
results were reproduced with two different adenovirus recombinants for 
both lacZ and p53. Particle content was determined by optical density at 
260 nm according to standard procedures (14). The ratio of infectious titer 
to particle content routinely obtained in our laboratory is ~1/100. The 
measurements for the lacZ and p53 adenovirus recombinants were found 
to be in the same range, at 1/110 and 1/120, respectively. 
Previous results have indicated the emergence of El-containing, repli- 
cation-competent virus contamination in stocks of replication-defective 
adenovirus after serial passage (24). To verify the purity of virus stocks, 
both PCR and Southern blot analysis for the detection of any contaminat- 
ing El-containing virus were carried out. For PCR analysis, recombinant 
viral DNA was extracted  and PCR  amplification was carried  out with 
primers specific for the E1 region (24). DNA derived from wild-type virus 
was used as a  positive control. When wild-type contamination was de- 
tected, results were confirmed by Southern blots in which the wild-type 
and recombinant viral DNAs were probed with fragments corresponding 
to the E1 and E2 region of the viral genome (24). For pure preparations, 
hybridization with a probe for the E1 region should reveal a positive sig- 
nal in wild-type only, while the probe for E2, a region present in both re- 
combinant and wild-type virus, should produce a single band indicating a 
pure population of virus in both DNA preparations. If traces of wild-type 
contamination were detected,  recombinant viruses were further plaque 
purified according to Graham and Prevec (14).  All vector preparations 
used for experiments were free of wild-type contamination. 
The HSV vector (RH105) was constructed by Ho and Mocarski (16). 
This recombinant virus carries the E.  coil lacZ gene inserted in the  TK 
gene upstream of the immediate early promoter ICP4. The disrupted TK 
gene renders the virus replication incompetent in postmitotic cells such as 
neurons (3, 8, 23, 37). The virus was propagated on Veto cells until a 
100% cytopathic effect was observed, after which time cells were freeze 
thawed and sonicated on ice to release virus particles. Large cell debris 
was removed by centrifugation at 1,800 g for 10 min. The resulting super- 
natant was then layered on a 25% sucrose cushion in PBS and centrifuged 
at 70,000 g for 18 hours. The pellet containing recombinant herpes Virus 
was resuspended in PBS and titered on Vero cells. The absence of wild- 
type virus was confirmed by X-gal staining of plaques generated on Vero 
cells. 
Multiplicity of infection (MOI) t was calculated based on titration on 
293  cells for adenovirus-based vectors and on Vero  cells for  the HSV 
RH105 vector, and represents the number of plaque-forming units added 
per cell. 
Cell Culture 
Mass cultures of purified sympathetic neurons were prepared according to 
the procedure of Ma et al. (25). Superior cervical ganglia were removed 
from newborn Sprague-Dawley rat pups (Charles River Breeding Labora- 
tories, Inc., Wilmington, MA) and collected in L15 medium without so- 
dium bicarbonate. The ganglia were washed in PBS (pH 7.4) and treated 
with 0.1%  trypsin (Calbiochem-Behring Corp., San Diego, CA) at 37°C 
for 20 min, followed by treatment with DNase (10 Ixg,/ml;  Sigma Chemical 
Co., St. Louis, MO) for 2 min. Ganglia were triturated and passed through 
a 40-p~m mesh (Falcon Labware, Oxnard, CA) to yield a  single cell sus- 
pension. After centrifugation in a clinical centrifuge, the pellet was resus- 
pended in L15 medium supplemented with sodium bicarbonate (30 mM), 
vitamin C (l ~g/ml), cytosine arabinoside (10 IxM), 3% rat serum, and 50 
ng/ml NGF (Cedarlane Laboratories, Ontario, Canada). Cells were plated 
at a density of 100,000 cells per ml medium on rat tail collagen-coated tis- 
sue-culture dishes. As previously stated (25),  these cells are essentially 
free of nonnenronal cells. Cultured neurons were allowed to mature and 
to extend processes for 3 to 5 d before viral infection. For viral infection, 
medium was removed and replaced with 25%  of the usual volume con- 
taining the appropriate  titer of virus. Cells were incubated for 1 h  and 
dishes were rocked every 15 min, after which time the remaining 75% vol 
of medium was added to each dish. For long-term cultures, medium was 
changed every 3 d. 
Detection of f3-Galactosidase-positive Cells 
Staining for expression of the 13-galactosidase marker gene was performed 
for the times described in the figure legends. Cells were fixed with 0.2% 
glutaraldehyde in PBS (pH 7.4) for 15 min at 4°C. After two washes with 
PBS, cells were incubated for 18 h in X-gal stain (2 mM MgCIz,  1 mg/ml 
X-gal, 5 mM K3Fe(CN)6, and 5 mM K4Fe(CN)6 in PBS (pH 7.4). To esti- 
mate the percentage of cells that were infected, the total cell number and 
lacZ-positive cells were counted in five random fields. The data were ex- 
pressed as the average of two separate experiments with error bars repre- 
senting the range. The number of cells per field was 125 -+ 50 for experi- 
ment 1, and 200 -+ 59 for experiment 2. 
Cell Survival Assay 
Neurons were seeded at a density of 5,000 cells per well in 48-well tissue- 
culture dishes. Neurons were infected with varying titers of either ade- 
novirus or HSV-1 vectors and maintained for 2 to 10 d, as indicated in the 
text, for the assessment of cell survival. Cell viability was measured by the 
metabolic conversion of a tetrazolium salt into formazan salt according to 
the CellTiter 96 Assay Kit (Promega, Madison, WI). 
1. Abbreviations used in this paper:, i3-gal,  13-galactosidase;  HSV, herpes 
simplex virus; MOI, multiplicity of infection; MTT, 3-[4,5-dimethylthio- 
zol-2-yl]-2,5-diphenyl tetrazolium bromide; SCG, superior cervical ganglia. 
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Sympathetic  neurons  were  infected  with  the  recombinant  adenovirus 
AdSCA17LacZ at titers of 0, 10, 50, 100 and 500 MOI. After 7 d in culture, 
cells were fixed in 1.5% glutaraldehyde in 0.1  M  cacodylate buffer (pH 
7.2) for 2 h. In some experiments, neurons were infected with Adwtp53 at 
50 MOI for 2 d, and fixed in the same manner. After initial fixation, sam- 
ples were washed three times in 0.1  M  sodium cacodylate buffer, for 15 
min each wash. Specimens were postfixed on ice in 1% osmium tetroxide 
for 90 rain, dehydrated in ascending concentrations of ethanol and ace- 
tone,  and embedded in Epon-Araldite.  Thin-sections were cut, stained 
with uranyl acetate and lead citrate, and examined with a  transmission 
electron microscope (H-7100; Hitachi Ltd., Tokyo, Japan). Three separate 
grids containing 40 to 60 cells were examined for each specimen. 
Electrophysiology 
Recombinant adenovirus-infected and control SCG neurons were voltage 
clamped using whole-cell patch recording technique to measure outward 
potassium (K) currents (27). Briefly, postnatal day 1 superior cervical gan- 
glia (SCG) neurons cultured for 3 d, were infected with Ad5CA17LacZ at 
an MOI of 50 for 24 h, and allowed to survive for an additional 6 d (a total 
of 7 d) before electrophysiological recordings. The cells were fixed (2% 
paraformaldehyde/.2% glutaraldehyde) immediately after recording and 
stained with X-gal to detect  [3-galactosidase ([3-gal)  activity. Only cells 
that exhibited 13-galactosidase activity were considered to be infected neu- 
rons. Results presented in Fig. 5 are the average of recordings obtained 
from six cells for the adenovirus-infected samples and five cells for con- 
trois. 
The total outward current in SCG neurons is made up of three voltage- 
gated currents that differ in their kinetic and voltage-dependent proper- 
ties: a non-inactivating current (IK); a fast transient A-type current (IA); 
and a small slow transient A-type current (IAs) (26). By holding the mem- 
brane at different potentials, we were able to selectively activate one or 
two of the currents, and thus characterize individual currents by subtrac- 
tion techniques. Briefly, the membrane was held at a potential (-10 or 
-20 mV) where depolarizing steps evoked only IK. The IK currents were 
subtracted from total currents (IA+IK+IAs) evoked by steps to the same 
depolarizing potentials from a  more negative potential, -90 mV, to iso- 
late the A  currents. For measurement of the current density (pA/pF), IA 
and IK current amplitudes were determined from the current evoked by a 
voltage step to  +30 mV after each current was isolated from the other 
two, and divided by the cell capacitance (pF). Cell capacitance (pF) was 
obtained by integrating the capacity current evoked by a 10-mV hyperpo- 
larizing voltage step, and then dividing this current by the voltage step. 
Voltage steps were delivered by a computer-controlled stimulator. The 
software for stimulation, data acquisition, and analysis was written by Mr. 
A. Sherman (Alembic Inc., Montreal, Quebec). Membrane currents were 
filtered  with  an  amplifier  (EPC-7;  List  Biological  Laboratories,  Inc., 
Campbell, CA), sampled at 5 kHz, displayed, and stored online. For all 
experiments, the durations of the voltage steps were 125-ms steps. 
All experiments were done at room temperature  (21-24°C). The pi- 
pettes were filled with intracellular media (5 mM NaCI, 50 mM potassium 
acetate, 65 mM KF, 1 mM MgC12, 10 mM Hepes, (pH 7.4, adjusted with 
KOH, 10 mM EGTA, 0.5 mM CaCI2); the pipette current was balanced to 
zero with the pipette immersed in the bathing solution. The neurons were 
continuously superfused with extracellular solution (140 mM choline CI, 2 
mM NaC1, 5.4 mM KCI, 0.4 mM CaC12, 0.18 mM MgClz, 10 mM Hepes, 
pH 7.4, adjusted with NaOH, 5.6 mM glucose, 0.5 mM tetrodotoxin [TTX; 
Sigma Chemical Co.], 1.5 mM COC12, and pH 7.3-7.4) at a rate of 0.5 ml/ 
min  during the  recording  session. The  extracellular  solution  included 
pharmacological agents to block inward sodium and calcium currents, and 
calcium-dependent currents as previously described (26). 
Western Analysis 
For the detection of p53, cells were harvested in lysis buffer (40) 30 and 
48 h  after infection with a  titer of 50 MOI. Protein was separated on a 
10% acrylamide gel and transferred to a nitrocellulose membrane. After 
blocking for 2 h in 5% skim milk, filters were incubated in a mouse mAb 
directed against murine and human p53 (1:10) (Ab-1; Oncogene Science, 
Cambridge, MA) overnight at 4°C.  After five washes in TBST (.15 N 
NaC1, 20 mM Tris, pH 8.0, 0.1% Tween-20) (5 rain each), filters were incu- 
bated for 1 h at 25°C in a goat anti-mouse secondary antibody conjugated 
to HRP. Filters were again washed five times in TBST for 5  min each 
wash. Blots were developed by the enhance chemiluminescence system 
(ECL; Amersham Corp., Arlington Heights, IL) according to the manu- 
facturer's instructions. 
Immunofluorescence 
For immunofluorescence detection of human p53 delivered by adenovirus 
vectors, specimens were fixed for 5 rain in methanol/acetone (I:I) and ai- 
lowed to air dry for 5 min. After rehydration, cells were blocked in PBS 
containing 3% goat serum. A mouse mAb specific for an amino-terminal 
epitope of human p53 (DO-l)  (Santa Cruz Biotechnology, Santa Cruz, 
CA) was used. The primary antibody was diluted in this same blocking so- 
lution (1:50)  and incubated on coverslips overnight at 4°C. After three 
washes in PBS, a  goat anti-mouse secondary antibody conjugated with 
Cy3 (diluted at 1:2000; Jackson Immunoresearch Laboratories, Inc., West 
Grove, PA) was applied to coverslips and incubated for 1 h at 25°C. After 
three washes in PBS, coverslips were mounted in glycerol and examined 
with a microscope (Axioskop; Carl Zeiss, Inc., Thornwood, N J). 
Isolation of Fragmented DNA 
To examine DNA fragmentation, 106 neurons were seeded on a  60-ram 
dish under the usual culture conditions. Ceils were infected with recombi- 
nant adenovirus 3 d after plating and were harvested 48 h after infection. 
Cells were harvested, washed once with PBS, and used for DNA isolation 
as described previously (40). 1.2 ml lysis buffer was added to 100 ~l of ceils 
suspended in TE (10 mM Tris-HCL, pH 8.0, and 1 mM EDTA). Lysis was 
allowed to proceed at room temperature for 15 min after which the lysate 
was centrifuged for 15 min at 12,000 rpm. The gelatinous pellet was re- 
moved with a  pipette, and the supernatant was digested with 100 ~g/ml 
RNase A  at 37°C for 30 rain. The DNA was then precipitated by adding 
an equal volume of 100% ethanol and NaC1, such that the final concentra- 
tion was 0.5 M. After centrifugation, the pellet was washed with 70% eth- 
anol and resuspended in 50 I~l of TE buffer. Fragmented DNA was end la- 
beled  with  [32p]dCTP  using Klenow  (Promega)  for  15  min  at  room 
temperature. DNA ladders were resolved by running end-labeled DNA 
on a 2% agarose gel using a 100-bp ladder as a standard. 
TUNEL Staining 
To assay apoptosis immunohistochemicaily,  terminal transferase was used 
to visualize fragmented DNA (TUNEL staining). Parallel cultures were 
infected with Adwtp53 or Ad5CA171acZ at 50 MOL After 72 h cells were 
fixed in acetone/methanol (1:  1) for 10 min at -20°C. 50 ixl of a cocktail 
consisting of 1.0  ;~l biotin dUTP (catalogue 109307;  Boehringer Mann- 
heim Biochemicals, Indianapolis, IN),  1.5  p~l terminal transferase (cata- 
logue M187/1; Promega), 20 p.l of 5  ×  terminal deoxy-transferase buffer 
(Promega), and 78 p.l distilled water was added to each coverslip. After a I h 
incubation at 37°C, coverslips were washed three times in PBS, pH 7.4, 
and once in TBS, pH 8.0, to stop the reaction. Coverslips were incubated 
with a streptavidin Cy3 (Jackson Immunoresearch Laboratories, Inc.) di- 
luted at 1:2,000 for 30 rain. After three 5-min washes in PBS, samples were 
mounted in glycerol and examined with a Zeiss Axioplan microscope. 
Results 
Gene Transfer Efficiency of Recombinant Adenovirus 
vs Herpes Simplex Virus in Sympathetic Neurons 
To determine the most effective and nontoxic gene trans- 
fer vector for postmitotic sympathetic neurons, we initially 
conducted  parallel  studies  with  the  adenovirus  vector, 
Ad5CA17LacZ,  and  the  herpes  simplex  virus-l-based 
vector, RH105 (16), both of which express the Escherichia 
coli 13-galactosidase (lacZ) reporter gene. Pure cultures of 
neonatal sympathetic neurons were infected with replica- 
tion-defective  viruses of both types at similar  titers and, 
48 h  after infection, were  stained with X-gal to visualize 
transgene  expression.  These  experiments  demonstrate 
that  both  herpes  simplex  virus  (HSV)-and  adenovirus- 
derived vectors are able to transduce sympathetic neurons 
in vitro (Fig.  1). Closer examination of lacZ staining and 
Slack et al. p53 lnduced Apoptosis in Postmitotic Neurons  1087 Figure 1.  Morphology of cultured sympathetic neurons after viral infection. Sympathetic neurons were isolated from P0 rat pups and 
cultured in 6-well dishes in medium containing 50 ng/ml NGF. At 72 h medium was removed and replaced with 25% of the medium con- 
taining virus. After 1-h incubation, the remainder of the medium was added to each well, and morphology was examined after 48 h. (A, 
C, and E) Cells infected with adenovirus at the following MOI: A, 1; C, 10; E, 100. (B, D, and F) Cells infected with herpes virus at the 
following MOI: B, 1; D, 10; F, 100. Bars: (D) 200 I~M; (F) 80 ~M. 
cell morphology, however,  indicated clear  differences in 
the efficacy of these two vectors. At titers of 1 MOI, ade- 
novirus vector infection led to a higher proportion of lacZ- 
positive neurons (Fig. 1, A  and B). At MOIs of 10, virtu- 
ally all of the adenovirus vector-infected neurons expressed 
the transgene, whereas many neurons in the HSV-l-infected 
cultures were negative (Fig. 1, C and D). At the highest ti- 
ter of 100 MOI, neurons infected with adenovirus recom- 
binants  appeared  normal  morphologically, exhibiting no 
indication of cytotoxicity, and  transgene  expression  was 
high  enough  that  both  cell  bodies  and  processes  were 
stained (Fig. 1  E). In contrast, neurons infected with the 
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HSV-1 vector, with 75 %  and 50% lacZ-positive cells in the 
sister  cultures,  respectively  (Fig.  2).  Titers  of I>100 MOI 
with either vector resulted  in transduction  of >95%,  but 
remarkable  differences  in  cytotoxicity  became  evident. 
We  therefore  assessed  cell  survival  after  infection  with 
these two different vectors. 
Neuronal Survival After Recombinant Virus Infection 
To assess potential cytotoxicity in response to viral infec- 
tion, sympathetic neurons were infected with varying titers 
of the  adenovirus  Ad5CA17LacZ or the  HSV-1  RH105 
vectors, and mitochondrial function was assayed 10 d later 
(Fig. 3). At 1 MOI, there was no significant difference in 
cytoxicity between  cells  infected  with  recombinant  ade- 
novirus  and  those  infected  with  recombinant  HSV-1. 
However, as titers were increased, a sharp decrease in cell 
viability was evident;  at  10 MOI, 90%  of the  neurons in 
the  adenovirus  vector-infected  cultures  remained  alive, 
whereas  only 45%  of those in the HSV-infected  cultures 
were alive. When these values are corrected for infectivity, 
it  appears  that  almost  all  cells  transduced  with  the  HSV 
vector were lost after 10 d in culture (e.g., at 10 MOI HSV, 
55%  of cells were infected and 55% of cells were lost). In 
contrast,  when  adenovirus  vector-infected  neurons  are 
corrected for infectivity data (i.e., 75 %  infected/10% lost), 
only 13% of infected cells were lost 10 d after infection at 
10 MOI. A  more striking difference appeared at 50 MOI; 
at this level of infection, the majority of the neurons in the 
HSV-infected cultures were lost (90%), while in adenovi- 
rus  vector-infected  cultures,  only  15%  of neurons  were 
lost. It appears therefore that HSV-1 has a  relatively nar- 
row  effective  range,  and  titers  necessary  to  transduce 
Figure 2.  Infectivity comparison between recombinant adenovi- 
rus  and  HSV-1.  Sympathetic neurons  were  isolated  from  new- 
born rat pups and cultured in 6-well dishes in medium containing 
50 ng/ml NGF. At 72 h ceils were infected with virus and infectiv- 
ity was assayed by X-gal staining after 48 h. (A) Neurons infected 
with recombinant adenovirus; (B) neurons infected with recom- 
binant HSV-1. To estimate the percentage of ceils that were in- 
fected, the total cell number and lacZ-positive cells were counted 
in five random fields. The data are expressed as the average of 
two separate experiments with error bars representing the range. 
The number of cells per field was 125  _+ 50 for experiment 1, and 
200 _+ 59 for experiment 2. 
HSV vector at 100 MOI displayed severe degeneration of 
neuritic processes within 48 h (Fig. 1 F). 
Quantitation of the number of lacZ-positive cells in sis- 
ter  cultures  of sympathetic  neurons  infected  with  these 
two viral  vectors confirmed these  qualitative  conclusions 
(Fig. 2).  While ~30%  of sympathetic neurons  were  lacZ 
positive after recombinant adenovirus infection at titers of 
1 MOI (Fig. 2 A), only 10% were transduced by the HSV 
vector at a similar titer (Fig. 2 B). At 10 MOI, transduction 
Figure 3.  Comparison of neuronal viability  after infection with 
recombinant adenovirus and HSV-1. Sympathetic neurons were 
isolated from newborn rat pups and infected with either recombi- 
nant  adenovirus  (black  bars) or recombinant HSV-1  (hatched 
bars) after 72 h in culture. Cell survival was measured by the met- 
abolic conversion of the tetrazolium salt into a formazan salt ac- 
cording to the Cell Titer 96 Assay Kit 10 d after infection. Bars 
represent  the mean of three separate  samples,  with error bars 
representing the standard error. 
Slack et al. p53 Induced  Apoptosis in Postmitotic  Neurons  1089 Figure 4.  Changes in cytoarchitecture of sympathetic neurons after infection with recombinant adenovirus. Sympathetic neurons were 
infected with Ad5CA17LacZ after 72 h in culture and were fixed for EM 7 d later. Cells were harvested in 1.5% glutaraldehyde in 0.1 M 
cacodylate buffer, pH 7.2. Specimens were processed for EM as described. (A) Uninfected sympathetic neuron showing normal cytoar- 
chitecture. (B) Neurons after infection with 10 MOI adenovirus. Cells are indistinguishable from controls except for a number of small 
electron-dense inclusions found in the nucleus (arrows). (C) Neurons after infection at 50 MOI adenovirus exhibited normal cytoarchi- 
tecture with electron-dense nuclear inclusions. (D) Neurons infected at 100 MOI exhibited significant deterioration of cytoarchitecture. 
Ceils exhibited chromatin disintegration (asterisks), very large electron-dense inclusions (arrows), and aggregates of filaments in nucleus 
(arrowhead). Bars: (A) 0.3 I~m;  (B) 0.5 I~m;  (C and D) 0.7 Ixm. 
>75%  of the cell population exhibit severe cytotoxic ef- 
fects. The results indicate that recombinant adenovirus, at 
titers of 10 to 50 MOI, can transduce >70% of cells with 
minimal cytotoxicity up to 10 d. All further experimentation 
therefore was carried out with adenovirus-based vectors. 
Cytoarchitecture  of Transduced Neurons 
While cells appeared normal and continued to survive af- 
ter infection with adenoviral recombinants, EM was car- 
ried out at 7 d after infection to determine if the presence 
of a nonlytic virus carrying the reporter gene caused ultra- 
structural changes in surviving neurons. We first examined 
cells infected at the lower range of 10 MOI, which resulted 
in the transduction of ~70% of ceils. The ultrastructure of 
these cells in general was indistinguishable from controls 
(Fig. 4 A); cells exhibited normal cytoplasms with healthy 
intact organelles, as well as nuclei containing normal chro- 
matin (Fig.  4 B). In some cells very small electron-dense 
inclusions  (Fig.  4  B)  were  found in  nuclei  of otherwise 
healthy cells.  At 50 MOI, cell organelles remained intact 
and nuclear structure appeared normal, although slightly 
more nuclear inclusions were visible (Fig. 4 C). 
At  higher  concentrations  of adenovirus  vector where 
significant cytotoxicity was  evident,  as  assayed by mito- 
chondrial function, nuclear abnormalities were readily ap- 
parent (Fig. 4 D). These included large electron-dense in- 
clusions as well as an accumulation of filamentous aggregates 
that are commonly found in neurons undergoing degener- 
ation, At high titers some neurons exhibited disintegration 
of chromatin (Fig,  4 D).  Ultrastructural  examination re- 
vealed no features characteristic of apoptosis even at the 
highest titers examined (500 MOI) relative to uninfected 
controls. These results indicate that recombinant adenovi- 
rus can be used at titers  that infect the majority of cells 
without  provoking  adverse  cytological  changes.  Vector 
concentrations, however, should be carefully controlled, as 
excessive infection rates result in deterioration of nuclear 
structure. 
Electrophysiological Function of Neurons Infected 
With Recombinant Adenovirus 
Although cells infected with 10 to 50 MOI of recombinant 
adenovirus  were  normal  with  respect  to  mitochondrial 
function and cytoarchitecture, we determined whether the 
presence of vector modified neuronal function in any way 
by characterizing the electrophysiological properties. Spe- 
cifically,  we examined K currents on sympathetic neurons 
infected  with  Ad5CA17LacZ at  50  MOI  for  7  d  using 
whole-cell patch clamp.  Previously, we  have shown that 
the total outward current in uninfected sympathetic neu- 
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Figure  5. Voltage-gated  K 
currents  on  adenovirus- 
infected,  13-galactosidase- 
expressing sympathetic neu- 
rons.  (A)  Voltage-gated  K 
currents on sympathetic neu- 
rons  infected  at  50  MOI 
Ad5CA17LacZ for 7  d  rela- 
tive  to  control,  uninfected 
sympathetic  neurons.  (Up- 
per panel; IK)  Depolarizing 
voltage steps from  a  Vh  of 
-10  mV  activate  only  a 
slowly activating, non-inacti- 
vating  current  (IK).  IA 
(lower panels) was  isolated 
by subtracting currents from 
Vh  of  -40  mV  (]K+IAs) 
from the corresponding cur- 
rents  evoked from  a  Vh  of 
-90 mV (IK+IAs+IA). (B) 
K  current  densities are  not 
altered by adenovirus vector 
infection: current density dis- 
tribution of IK  and  IA  for 
control and Ad5CA17LacZ- 
infected SCG neurons.  Cur- 
rent  densities (pA/pF) were 
measured  as  the  peak  iso- 
lated K current (pA) divided 
by  the  membrane  capaci- 
tance  (pF). Only SCG  neu- 
rons from which electrophys- 
iological  recordings  were 
obtained  and  which  exhib- 
ited [3-gal activity were con- 
sidered to be infected neurons 
(n  =  6  for  [3-galactosidase- 
positive neurons;  n  =  5  for 
control neurons). 
rons is made up of three voltage-gated currents that differ 
in their kinetic and voltage-dependent properties: a  non- 
inactivating current  (IK); a  fast transient  A-type current 
(IA) that inactivates with a time course of 10-30 ms; and a 
slow transient A-type current  (IAs) that inactivates with 
two components, one with a time constant of 100-300 ms, 
and the other with a time constant of 1-3 s (26). In sympa- 
thetic neurons expressing [3-galactosidase 7  d  after infec- 
tion,  the  current  densities  (pA/pF) for  IK and  IA were 
found to be similar to those previously reported for cul- 
tured  SCG  neurons  (27)  and  not  significantly different 
from  those of control, uninfected  SCG  neurons  (Fig. 5). 
Neurons infected at 50 MOI with recombinant adenovirus 
therefore appear to function normally for up to 7 d. 
Overexpression  of  p53 Induces Apoptotic Cell Death in 
Postmitotic Neurons 
These  results indicated that  adenovirus vectors could be 
used  to  genetically manipulate  primary  neurons  within 
controlled parameters. We therefore used this approach to 
determine whether overexpression of p53 was sufficient to 
induce programmed cell death in postmitotic neurons.  A 
recombinant  adenovirus  [Adwtp53]  carrying a  wild-type 
p53  expression cassette on the same pJM17 vector back- 
bone as the lacZ reporter gene was used for these studies. 
Initially, to determine if adenovirus-mediated delivery of 
the human wild-type p53 could lead to stable overexpres- 
sion in cultured sympathetic neurons,  cells were infected 
at 50 MOI with recombinant adenoviruses carrying either 
human  p53  [Adwtp53]  or lacZ [Ad5CA17LacZ]  and im- 
munostained with an antibody specific for human p53. As 
predicted, neurons infected with Ad5CA17LacZ were not 
immunoreactive for human p53 (Fig. 6 A), while those in- 
fected with Adwtp53 exhibited strong nuclear staining in 
>80% of cells (Fig. 6 B). 
To determine more precisely the extent of p53 overex- 
pression relative to endogenous levels, transduced sympa- 
Slack et al, p53 lndueed Apoptosis in Postmitotic Neurons  1091 Figure 6.  Human p53 overexpression is localized to the nucleus 
of sympathetic neurons. 3 d  after plating on coverslips,  sympa- 
thetic neurons were infected with recombinant adenovirus encod- 
ing I~-galactosidase (AdCA171acZ) (A), or human wild type p53 
(Adwtp53) (B). 48 h after infection, cells were fixed in acetone/ 
methanol (I: 1) for 5 min and stained with an mAb (DO-l) that 
reacts specifically with human p53. Arrows point to pyknotic nu- 
clei overexpressing human p53. Bar, 20 IJ,  M. 
thetic neurons were harvested  at 30 and 48 h  after infec- 
tion with 50 MOI of Ad5CA17LacZ or Adwtp53, and the 
levels of p53 protein were examined by Western blot anal- 
ysis With an antibody that recognized both rodent and hu- 
man  p53.  These  experiments  demonstrated  that  endoge- 
nous p53 was stably expressed in sympathetic neurons, and 
that infection with Ad5CA17LacZ did not affect endoge- 
nous p53 expression  (Fig. 7 B). In contrast, by 30 h  after 
infection with Adwtp53, p53 protein was detectably over- 
expressed in sympathetic neurons (Fig. 7 A), while by 48 h, 
expression was much higher than endogenous levels (Fig. 
7  B).  Coincident with this increased expression  of p53  at 
48 h  after infection, morphological changes characterized 
by  cell  shrinkage  became  evident  in  cells  infected  with 
Adwtp53,  while  those carrying Ad5CA17LacZ appeared 
normal. Moreover, a noticeable number of dead and pyk- 
Figure  Z  Overexpression  of p53  as  detected  by Western  blot 
analysis.  (A) Neurons were infected with Adwtp53 at 50 MOI 
and  harvested  after 30 h. Lysates containing protein  extracted 
from 100,000 cells were loaded on each lane, and Western blots 
were probed with a mouse mAb Ab-1 that reacts with both ro- 
dent and human p53.  (Lane 1) Uninfected neurons; (lane 2) in- 
fected neurons showing expression of the p53 protein. (B) Neu- 
rons were uninfected (lane 1), infected with 50 MOI Ad5CA171acZ 
(lane 2),  or infected with 50 MOI Adwtp53  (lane 3)  and  har- 
vested 48 h after infection. Western blots were performed as for 
A. (C) Overexpression of p53 leads to DNA fragmentation. Neu- 
rons  were  infected  with  50  MOI  of  recombinant  adenovirus 
Ad5CA17LacZ (lane l) or Adwtp53 (lane 2) and harvested 48 h 
after infection. Nucleosomal DNA was extracted  from 300,000 
cells  (each  sample)  and  end  labeled  with  [32P]dCTP. Samples 
were run on a 2% agarose gel, dried, and visualized  with a phos- 
phorimager. M, molecular weight markers. 
notic, p53-positive neurons were observed (Fig. 6 B) rela- 
tive  to  controls,  suggesting  that  overexpression  of  p53 
leads to neuronal death. 
To  quantitate  the  extent  of neuronal  death  after  p53 
overexpression, cell survival was measured with the 3-[4,5- 
dimethylthiozol-2-yl]-2,5-diphenyl  tetrazolium  bromide 
(Mq'T) metabolic assay. 3 d after plating sympathetic neu- 
rons  were  infected  in  parallel  with  Ad5CA17LacZ  and 
Adwtp53 at titers ranging from 5-500 MOI. The Mq-T sur- 
vival assay of lacZ-infected neurons  revealed no changes 
in  cell  viability  72  h  after  infection  even  at  the  highest 
MOI  of 500  (Fig.  8  A).  In  contrast,  cells  infected  with 
Adwtp53 under identical  conditions exhibited  a  40%  de- 
crease in cell survival at 5 MOI and a  65%  decrease at 10 
MOI (Fig.  8 A). Higher levels of virus resulted  in a  dra- 
matic 75-85%  loss  of cell  viability  by 72  h.  As  an  addi- 
tional control, sister cultures were infected with wild-type 
adenovirus  at  similar  MOIs.  Surprisingly,  even  wild-type 
adenovirus did not affect the survival of sympathetic neu- 
rons for up to 72 h (Fig. 8 A). 
These data indicated that overexpression of human p53 
leads  to the  death  of sympathetic  neurons.  To  ascertain 
the  time  course  of neuronal  cell  death  after p53  overex- 
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Figure 8.  Recombinant adenovirus-mediated expression  of p53 
leads to death of postmitotic sympathetic neurons.  (A) Neurons 
were infected in parallel with wild-type adenovirus,  recombinant 
adenovirus (Ad5CA17LacZ), and a recombinant adenovirus car- 
rying wild-type p53 (Adwtp53)  at titers of 0, 5, 10, 50, 100, and 
500 MOI. After 72 h cell survival was measured by metabolic 
conversion of tetrazolium salt into formazan salt using a Cell Titer 
96 Assay Kit. Results  are the average of three separate experi- 
ments, with error bars representing standard error. (B) Neurons 
were infected in  parallel  with  recombinant adenoviral vectors 
carrying LacZ (Ad5CA17LacZ) and p53 (Adwtp53)  at a titer of 
50 MOI. After a time course of 2, 2.5, 3, 5, and 7 d, cell survival 
was  measured  as described  for A. Results are the average of two 
separate experiments, with error bars representing range. 
pression, parallel experiments were carried out with neu- 
rons infected at 50 MOI with Ad5CA17LacZ and Adwtp53. 
Survival was measured by M'Iq" assay at 2, 2.5, 3, 5, and 7 d 
after infection. Neuronal cell death was first detectable by 
48 h when a 10% decrease in cell survival was evident (Fig. 
8 B). By 72 h a dramatic 60-70%  loss in cell viability was 
detected. Cell death then continued at a very low level for 
the remainder of the assay. Thus, cell death begins 48 h af- 
ter infection with Adwtp53, with the majority of neurons 
dying between 2 and 3 d. 
To determine if p53-induced cell death was due to apop- 
tosis we conducted three different assays: (a) the isolation 
of nucleosomal DNA to visualize DNA ladders; (b) TUNEL 
staining  to  visualize  apoptosis  immunohistochemically; 
and  (c) EM.  All three  of these  assays, which were con- 
ducted  in parallel with cultures  infected at 50 MOI with 
Ad5CA17LacZ  or  Adwtp53,  indicated  that  overexpres- 
sion of p53 leads to neuronal apoptosis. First, neurons in- 
fected for 48 h  with Adwtp53  showed significantly more 
DNA fragmentation than those infected with Ad5CA17LacZ 
(Fig. 7  C), as demonstrated by DNA gel electrophoresis. 
Second, TUNEL staining revealed significantly higher lev- 
els of apoptosis in neurons overexpressing p53 relative to 
controls  at  72  h  after  infection  (Fig.  9,  A  and  B).  In 
Adwtp53-infected  cultures  there  were  many  pyknotic, 
TUNEL-positive nuclei  (Fig.  9  F),  while  only the  occa- 
sional TUNEL-positive nucleus was observed in cultures 
infected with  Ad5CA17LacZ  (Fig.  9, A  and D).  Coinci- 
dent with this  increase  in TUNEL labeling, p53-overex- 
pressing neurons displayed dramatic neuritic degeneration 
(Fig. 9 E), while those expressing lacZ displayed normal 
morphology (Fig. 9 C). Finally, analysis of these cultures 
by EM demonstrated enhanced  apoptosis of sympathetic 
neurons infected with 50 MOI Adwtp53,  as indicated  by 
chromatin collapse and condensation (data not shown). In 
contrast, sympathetic neurons infected with Ad5CA17LacZ 
did not display enhanced apoptosis relative to uninfected 
controls, even at 500 MOI, at least as measured ultrastruc- 
turally. Thus, adenovirus-mediated overexpression of p53 
is  sufficient  to cause  the  apoptotic death  of postmitotic 
sympathetic neurons. 
Discussion 
The data presented  in this paper support two important 
conclusions.  First,  we  demonstrate  that  adenovirus- 
derived  vectors  can  be  effectively used  as  gene  transfer 
agents  for postmitotic  neurons.  When  used  between  10 
and 50 MOI, recombinant adenovirus can infect >75% of 
sympathetic neurons  with  little  perturbation  in  cell  sur- 
vival, cytoarchitecture,  and  physiological function  for at 
least 7 d after infection. Secondly, working within the pa- 
rameters we have defined with the Ad5CA17LacZ recom- 
binant adenovirus, we have demonstrated that overexpres- 
sion of p53 is sufficient to induce programmed cell death 
in postmitotic neurons. 
The observation that overexpression of the tumor sup- 
pressor, p53,  is sufficient to induce  apoptosis in postmi- 
totic neurons has major implications for the mechanisms 
of cell death in the  traumatized  nervous system. Recent 
studies have demonstrated p53 upregulation during acute 
neurological disease such as transient middle cerebral ar- 
Slack et al. p53 Induced Apoptosis in Postmitotic Neurons  1093 Figure 9.  TUNEL staining reveals enhanced apoptosis in neurons overexpressing p53. Neurons were infected at 50 MOI with either 
Adwtp53 or Ad5CA171acZ. After 72 h, cells were fixed with methanol/acetone (1:1) for 10 rain and treated with a cocktail containing the 
terminal transferase enzyme and biotin-dUTP. Incorporation of biotin-dUTP was detected by Cy3-conjugated streptavidin. A  and B 
were photographed at low magnification to show a  representative  sampling of the cell  population. A  markedly enhanced level of 
TUNEL staining is observed in cells overexpressing p53 (B) relative to neurons expressing lacZ (A). At higher magnification, phase 
contrast of the same fields reveals degeneration of neuritic processes in cell infected with Adwtp53 (E) relative to controls (C). The cor- 
responding TUNEL staining (D, cells infected with Ad5CA171acZ; and F, cells infected with Adwtp53) shows pyknotic nuclei indicative 
of apoptosis in cells infected with Adwtp53 (F). Bars: (A) 400 lxM; (C) 160 ixM. 
tery occlusion (22) and kainic acid-induced excitotoxicity 
(36).  Furthermore,  p53  has  been  implicated  in  apoptosis 
after  ionizing  radiation  in  cerebellar  granule  cells  (42). 
Since our data indicate that endogenous p53 is stably ex- 
pressed in SCG neurons, it appears that this protein must 
be expressed  at  a  given threshold  level before  the  apop- 
totic pathway is triggered. Once this threshold is reached, 
our data indicate that p53 alone is sufficient to induce neu- 
ronal  apoptotic  cell  death,  suggesting  that  the  upregula- 
tion of p53 after neuronal injury may well be the key signal 
leading to the demise of injured neurons in at least some 
situations. 
In contrast to the proposed role for p53 in stress-induced 
neuronal  death,  this  protein  does  not  apparently  play  a 
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null mutations for p53 develop normally (7), and neurons 
derived  from  such  mice  exhibit  normal  apoptosis  after 
neurotrophin withdrawal (5). Moreover, no enhancement 
of p53 expression was observed after NGF withdrawal in 
sympathetic neurons (13). Together, these studies indicate 
that if p53 does play a role during naturally occurring neu- 
ronal death, it is of relatively minor developmental impor- 
tance. 
It is somewhat surprising that p53 mediates apoptosis in 
neurons, since these cells are postmitotic, and thus pose no 
apparent  threat  of  tumorigenesis.  In  cycling  cells,  the 
DNA-binding function of p53 is essential to mediate cell 
cycle arrest (34). However, the functional domains of p53 
required to induce apoptosis are less well defined. A num- 
ber of studies  suggest  that p53-mediated transactivation 
may induce apoptosis in some cell types (28, 29, 32, 35). In 
particular, recent studies indicate that cross talk may exist 
between p53  and the  bcl-bax signaling cascade (17, 30). 
The gene for bax (30), one member of the bcl2 family that 
induces apoptosis, contains p53 consensus sites in its pro- 
moter (29). Wild-type but not mutant p53 was shown to 
transactivate the bax promoter and gel retardation assays 
demonstrated that p53 could directly bind the p53 consen- 
sus sequence of this promoter (28). The fact that p53-medi- 
ated apoptosis can be inhibited by overexpression of bcl-2 
is consistent with the interpretation that the bcl-bax path- 
way is downstream of p53 (for review see 41). 
Although p53 may mediate neuronal apoptosis via tran- 
scriptional activation, alternative mechanisms cannot yet 
be ruled out (4). For example, in other systems, p53 can in- 
hibit transcription of genes required for cell survival by 
physically interacting with and inhibiting the single-stranded 
DNA-binding protein complex replication protein A (9, 21). 
Moreover,  other  transcription-independent  mechanisms 
have recently been implicated in p53-mediated apoptosis 
of cell types other than neurons (for review see 41). Thus, 
the mechanism by which p53-induced cell death occurs is a 
function of the cell type and situation. Future studies using 
adenovirus-derived vectors to introduce p53 deletion mu- 
tants will help to define the mechanism of p53 action in 
postmitotic neurons. 
The studies described here also demonstrate the use of 
recombinant adenoviral vectors for carrying out mechanis- 
tic studies in postmitotic neurons. We have found that ti- 
ters sufficiently high to transduce the majority of neurons 
can  be  used  without  perturbing  cell  survival,  neuronal 
function, or cytoarchitecture. It should be noted, however, 
that there are definite limitations with respect to transduc- 
tion levels that sympathetic neurons are able to tolerate. 
At  titers  in excess of 100 MOI,  assays of mitochondrial 
function indicate a decrease in cell survival. Cells surviving 
excessive infection rates exhibited remarkable changes in 
the  nuclear  ultrastructure  manifested  by  electron-dense 
inclusions, filamentous aggregates,  and,  in  severe cases, 
disintegration of chromatin. The nature of these inclusions 
is unknown and clearly distinct from either the cytopathic 
effect induced by wild-type adenovirus in respiratory epi- 
thelial cells, or apoptosis.  Pathological changes resulting 
from  recombinant viral  transduction  is  an  area  that  re- 
quires further investigation, particularly with regards to vi- 
ral-mediated gene therapy. 
In conclusion, adenovirus vectors provide valuable tools 
to examine molecular pathways in postmitotic neurons. By 
using these vectors, we'have shown that overexpression of 
p53 is sufficient to induce apoptosis in sympathetic neu- 
rons. These results suggest that the signaling cascade re- 
sponsive to p53 is functional in postmitotic neurons and 
may well be a key regulator of cell death in the trauma- 
tized nervous system. 
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